Correlation Between Naver and Medy Tox
Can any of the company-specific risk be diversified away by investing in both Naver and Medy Tox at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Naver and Medy Tox into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Naver and Medy Tox, you can compare the effects of market volatilities on Naver and Medy Tox and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Naver with a short position of Medy Tox. Check out your portfolio center. Please also check ongoing floating volatility patterns of Naver and Medy Tox.
Diversification Opportunities for Naver and Medy Tox
Pay attention - limited upside
The 3 months correlation between Naver and Medy is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Naver and Medy Tox in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medy Tox and Naver is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Naver are associated (or correlated) with Medy Tox. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medy Tox has no effect on the direction of Naver i.e., Naver and Medy Tox go up and down completely randomly.
Pair Corralation between Naver and Medy Tox
Assuming the 90 days trading horizon Naver is expected to generate 0.56 times more return on investment than Medy Tox. However, Naver is 1.79 times less risky than Medy Tox. It trades about 0.21 of its potential returns per unit of risk. Medy Tox is currently generating about -0.14 per unit of risk. If you would invest 16,530,000 in Naver on September 3, 2024 and sell it today you would earn a total of 4,120,000 from holding Naver or generate 24.92% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Naver vs. Medy Tox
Performance |
Timeline |
Naver |
Medy Tox |
Naver and Medy Tox Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Naver and Medy Tox
The main advantage of trading using opposite Naver and Medy Tox positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Naver position performs unexpectedly, Medy Tox can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medy Tox will offset losses from the drop in Medy Tox's long position.Naver vs. Ilji Technology Co | Naver vs. Haitai Confectionery Foods | Naver vs. Formetal Co | Naver vs. Seoul Food Industrial |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |